Analyze Diet
Equine veterinary journal2022; 55(5); 820-830; doi: 10.1111/evj.13879

Risk factors for insidious uveitis in the Knabstrupper breed.

Abstract: Equine recurrent uveitis (ERU) is the leading cause of blindness for horses; previous research implicated the leopard complex spotting allele (LP) as a genetic risk factor for insidious uveitis in the Appaloosa. There is limited information about risk in the Knabstrupper. Objective: To evaluate clinical manifestations, disease frequency and potential risk factors for ERU in Knabstrupper horses. Methods: Cross-sectional study. Methods: Ocular examinations were performed on 116 horses, and based on identified anomalies, horses were classified as suspect, ERU-affected or having no clinical signs. Microagglutination testing (MAT) of serum assessed exposure to Leptospira spp. Clinical signs, age, sex, base colour, coat pattern, LP and PATN1 genotypes, percent white at birth, progressive roaning and Leptospira were assessed as risk factors using multivariable exact logistic regression, accounting for clustering at the barn level. Additionally, a pedigree analysis was performed (n = 20 cases and 21 controls), and coefficients of coancestry (CC) and inbreeding were calculated. Results: Prevalence of insidious uveitis in this sample of Knabstruppers was 20.7%. Similar to findings for Appaloosas, LP homozygotes had higher odds of uveitis compared with true solid (N/N) horses (LP/LP OR = 7.64, 95% CI [0.8 to +INF], p = 0.04) and age was also identified as a risk factor. After accounting for LP, the 16-20 age group had higher odds compared with the youngest group (OR = 13.36, 95% CI [1.4-213.4], p = 0.009). The distributions of average CC were significantly different between cases and controls (p = 0.01). Conclusions: A relatively small sample size decreased the power for detecting additional associations. The progressive nature of insidious uveitis may have prevented identification of younger affected horses. Conclusions: Our data support genotyping for LP to assess risk of ERU in Knabstruppers. Additional studies are necessary to develop more robust risk models across LP breeds for earlier detection and improved clinical management.
Publication Date: 2022-10-24 PubMed ID: 36199161DOI: 10.1111/evj.13879Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article investigates the risk factors associated with equine recurrent uveitis (ERU), a leading cause of blindness in horses, particularly in the Knabstrupper breed. Through a detailed examination of 116 horses, the study found a correlation between certain genotypes and age, concluding that additional studies were necessary for an improved understanding and management of ERU.

Research Methodology

  • The study was conducted as a cross-sectional type, with ocular examinations performed on 116 Knabstrupper horses.
  • Depending on identified anomalies, horses were classified as suspect, ERU-affected or free of clinical signs.
  • To assess exposure to Leptospira spp, microagglutination testing (MAT) of the serum was conducted.
  • Several risk factors were analyzed, including clinical signs, age, sex, base color, coat pattern, LP and PATN1 genotypes, percent white at birth, progressive roaning, and Leptospira.
  • All these factors were evaluated via multivariable exact logistic regression, taking into account potential clustering at the barn level.
  • An additional pedigree analysis involving 20 cases and 21 controls was carried out, with calculations for coefficients of coancestry (CC) and inbreeding.

Research Findings

  • The study found a 20.7% prevalence of insidious uveitis in the sample of Knabstrupper horses.
  • As with previous research focused on Appaloosas, LP homozygotes had higher odds of uveitis, categorized by an LP/LP OR of 7.64 (with a 95% CI of [0.8 to +INF]) and a statistical significance of p=0.04. This suggests a genetic risk factor to ERU linked to the LP allele.
  • Age was also identified as another significant risk factor. After accounting for LP, the 16-20 age group had higher odds compared with the youngest group with an OR of 13.36 (95% CI [1.4-213.4], p=0.009).
  • The comparison of average CC showed a significant difference between cases and controls, suggesting an element of genetic risk in terms of inherited traits.

Conclusions and Future Work

  • The study acknowledged that the relatively small sample size and insidious nature of uveitis may have limited the detection of younger affected horses and consequently affected the power for detecting other associations.
  • However, it was concluded that genotyping for LP could be an effective strategy for assessing the risk of ERU in Knabstrupper horses.
  • The research encourages further studies to develop robust risk models for early detection and improved clinical management of ERU, especially across LP breeds.

Cite This Article

APA
Kingsley NB, Sandmeyer L, Parker SE, Dwyer A, Heden S, Reilly C, Hallendar-Edman A, Archer S, Bellone RR. (2022). Risk factors for insidious uveitis in the Knabstrupper breed. Equine Vet J, 55(5), 820-830. https://doi.org/10.1111/evj.13879

Publication

ISSN: 2042-3306
NlmUniqueID: 0173320
Country: United States
Language: English
Volume: 55
Issue: 5
Pages: 820-830

Researcher Affiliations

Kingsley, Nicole B
  • Veterinary Genetics Laboratory, School of Veterinary Medicine, University of California - Davis, Davis, California, USA.
  • Department of Population Health and Reproduction, School of Veterinary Medicine, University of California-Davis, Davis, California, USA.
Sandmeyer, Lynne
  • Department of Small Animal Clinical Sciences, Western College of Veterinary Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
Parker, Sarah E
  • Department of Large Animal Clinical Sciences, Western College of Veterinary Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
Dwyer, Ann
  • Genesee Valley Equine Clinic, LLC, Scottsville, New York, USA.
Heden, Sanna
  • Distriktsveterinärerna, Falköping, Sweden.
Reilly, Camilla
  • Heste-Dyrlaegen, Taastrup, Denmark.
Hallendar-Edman, Anna
  • Department of Clinical Sciences, Swedish University of Agricultural Sciences, Uppsala, Sweden.
Archer, Sheila
  • Independent Researcher, Sayward, British Columbia, Canada.
Bellone, Rebecca R
  • Veterinary Genetics Laboratory, School of Veterinary Medicine, University of California - Davis, Davis, California, USA.
  • Department of Population Health and Reproduction, School of Veterinary Medicine, University of California-Davis, Davis, California, USA.

MeSH Terms

  • Animals
  • Horses
  • Cross-Sectional Studies
  • Horse Diseases / diagnosis
  • Uveitis / diagnosis
  • Uveitis / veterinary
  • Leptospira
  • Risk Factors

Grant Funding

  • Knabstrupperforeningen for Danmark
  • D16EQ-028 / Morris Animal Foundation
  • 18-17 / UC Davis Center for Equine Health

References

This article includes 35 references
  1. Spiess BM. Equine recurrent uveitis: the European viewpoint.. Equine Vet J 2010;42(S37):50-6.
  2. Kingsley NB, Sandmeyer LS, Bellone RR. A review of investigated risk factors for developing equine recurrent uveitis.. Vet Ophthalmol 2022;1-15.
    doi: 10.1111/vop.13002google scholar: lookup
  3. McMullen RJ, Fischer BM. Medical and surgical management of equine recurrent uveitis.. Vet Clin North Am - Equine Pract 2017;33(3):465-81.
  4. Thirstrup JP, Pertoldi C, Loeschcke V. Genetic analysis, breed assignment and conservation priorities of three native Danish horse breeds.. Anim Genet 2008;39(5):496-505.
  5. Baumgart A, Gerhards H. Besonderheiten der Tigerschecken-Uveitis und möglicher Cyclosporin A-Einsatz in deren Therapie in Deutschland.. Pferdeheilkunde 2014;30(6):626-32.
  6. Gilger BC. Equine recurrent uveitis: the viewpoint from the USA.. Equine Vet J 2010;42(S37):57-61.
  7. Fritz KL, Kaese HJ, Valberg SJ, Hendrickson JA, Rendahl AK, Bellone RR. Genetic risk factors for insidious equine recurrent uveitis in Appaloosa horses.. Anim Genet 2014;45(3):392-9.
    doi: 10.1111/age.12129google scholar: lookup
  8. Sandmeyer LS, Kingsley NB, Walder C, Archer S, Leis ML, Bellone RR. Risk factors for equine recurrent uveitis in a population of Appaloosa horses in western Canada.. Vet Ophthalmol 2020;23(3):515-25.
    doi: 10.1111/vop.12749google scholar: lookup
  9. Rockwell H, Mack M, Famula T, Sandmeyer L, Bauer B, Dwyer A. Genetic investigation of equine recurrent uveitis in Appaloosa horses.. Anim Genet 2020;51(1):111-6.
    doi: 10.1111/age.12883google scholar: lookup
  10. Bellone RR, Holl H, Setaluri V, Devi S, Maddodi N, Archer S. Evidence for a retroviral insertion in TRPM1 as the cause of congenital stationary night blindness and leopard complex spotting in the horse.. PLoS One 2013;8(10):1-14.
  11. Davidson MG, Nasiss MP, Roberts SM. Immunodiagnosis of leptospiral uveitis in two horses.. Equine Vet J 1987;19(2):155-7.
  12. Ackermann K, Kenngott R, Settles M, Gerhards H, Maierl J, Wollanke B. In vivo biofilm formation of pathogenic leptospira spp. in the vitreous humor of horses with recurrent uveitis.. Microorganisms 2021;9(9):1-14.
  13. Dwyer AE, Crockett RS, Kalsow CM. Association of leptospiral seroreactivity and breed with uveitis and blindness in horses: 372 cases (1986-1993).. J Am Vet Med Assoc 1995;207(10):1327-31.
  14. Wollanke B, Gerhards H, Brem S, Kopp H, Meyer P. Intraocular and serum antibody titers to Leptospira in 150 horses with equine recurrent uveitis (ERU) subjected to vitrectomy.. Berl Munch Tierarztl Wochenschr 1998;111(4):134-9.
  15. Brem S, Gerhards H, Wollanke B, Meyer P, Kopp H. 35 leptospira isolated from the vitreous body of 32 horses with recurrent uveitis (ERU).. Berl Munch Tierarztl Wochenschr 1999;112(10-11):390-3.
  16. Faber NA, Crawford M, LeFebvre RB, Buyukmihci NC, Madigan JE, Willits NH. Detection of Leptospira spp. in the aqueous humor of horses with naturally acquired recurrent uveitis.. J Clin Microbiol 2000;38(7):2731-3.
  17. Niedermaier G, Wollanke B, Hoffmann R, Brem S, Gerhards H. Detection of leptospira in the vitreous body of horses without ocular diseases and of horses with equine recurrent uveitis (ERU) using transmission-electron microscopy.. Dtsch Tierarztl Wochenschr 2006;113(11):418-22.
  18. Brandes K, Wollanke B, Niedermaier G, Brem S, Gerhards H. Recurrent uveitis in horses: vitreal examinations with ultrastructural detection of leptospires.. J Vet Med A Physiol Pathol Clin Med 2007;54(5):270-5.
  19. Pearce JW, Galle LE, Kleiboeker SB, Turk JR, Schommer SK, Dubielizig RR. Detection of Leptospira interrogans DNA and antigen in fixed equine eyes affected with end-stage equine recurrent uveitis.. J Vet Diagn Invest 2007;19(6):686-90.
  20. Gerding JC, Gilger BC. Prognosis and impact of equine recurrent uveitis.. Equine Vet J 2016;48(3):290-8.
    doi: 10.1111/evj.12451google scholar: lookup
  21. Williams RD, Morter RL, Freeman MJ, Lavignette AM. Experimental chronic uveitis. Ophthalmic signs following equine leptospirosis.. Invest Ophthalmol 1971;10(12):948-54.
  22. Gilger BC, Salmon JH, Yi NY, Barden CA, Chandler HL, Wendt JA. Role of bacteria in the pathogenesis of recurrent uveitis in horses from the southeastern United States.. Am J Vet Res 2008;69(10):1329-35.
    doi: 10.2460/ajvr.69.10.1329google scholar: lookup
  23. Matthews AG, Palmer MF. Serological study of leptospiral infections and endogenous uveitis among horses and ponies in the United Kingdom.. Equine Vet J 1987;19(2):125-8.
  24. Wollanke B, Gerhards H, Ackermann K. Infectious uveitis in horses and new insights in its leptospiral biofilm-related pathogenesis.. Microorganisms 2022;10(2):387.
  25. Bellone RR, Liu J, Petersen JL, Mack M, Singer-Berk M, Drögemüller C. A missense mutation in damage-specific DNA binding protein 2 is a genetic risk factor for limbal squamous cell carcinoma in horses.. Int J Cancer 2017;141:342-53.
    doi: 10.1002/ijc.30744google scholar: lookup
  26. Garbe J, Da Y. Pedigraph: A Software Tool for the Graphing and Analysis of Large Complex Pedigree. User Manual.. Published Online; 2008.
  27. Cunningham EP, Dooley JJ, Splan RK, Bradley DG. Microsatellite diversity, pedigree relatedness and the contributions of founder lineages to thoroughbred horses.. Anim Genet 2001;32(6):360-4.
  28. StataCorp. Stata Statistical Software.. Published Online; 2017.
  29. Cutler T, Brooks D, Andrew S, Denis HM, Biros DJ, Gelatt KN. Disease of the equine posterior segment.. Vet Ophthalmol 2000;3(2-3):73-82.
  30. Roberts S. Fundus lesion in equine periodic ophthalmia.. J Am Vet Med Assoc 1962;141:229-39.
  31. Lavach J. Pupil, iris, and ciliary body.. Large animal ophthalmology. St. Louis: Mosby Company; 1990. p. 150-77.
  32. Hussey GS, Goehring LS, Lunn DP, Hussey SB, Huang T, Osterrieder N. Experimental infection with equine herpesvirus type 1 (EHV-1) induces chorioretinal lesions.. Vet Res 2013;44(1):1-15.
    doi: 10.1186/1297-9716-44-118google scholar: lookup
  33. Sandmeyer LS, Bauer BS, Feng CX, Grahn BH. Equine recurrent uveitis in western Canadian prairie provinces: a retrospective study (2002-2015).. Can Vet J 2017;58:717-22.
  34. Wollanke B, Geiger T, Gerhards H. Evaluation of “SNAP® lepto”-ELISA and comparison with MAT and PCR results for diagnosis of leptospiral uveitis in horses using intraocular samples.. Pferdeheilkunde 2018;34(6):508-16.
    doi: 10.21836/pem20180601google scholar: lookup
  35. Geiger T, Gerhards H, Wollanke B. Detection of anti-lipl32 antibodies in serum samples from horses with chronic intraocular infection with leptospira spp.. Pathogens 2021;10(10):1325.
    doi: 10.3390/pathogens10101325google scholar: lookup

Citations

This article has been cited 1 times.
  1. Kirmse L, Thieme K, Doherr MG, Eule JC. Evaluation of Laboratory Techniques for the Diagnosis of Leptospira-Associated Equine Recurrent Uveitis (ERU) With Focus on the Goldmann-Witmer Coefficient. Vet Ophthalmol 2026 Jan;29(1):e70132.
    doi: 10.1111/vop.70132pubmed: 41518147google scholar: lookup